T
Tvardi Therapeutics, Inc. (TVRD)
NCM – Real Time Price. Currency in USD
3.98
+0.02 (0.51%)
At close: May 12, 2026, 4:00 PM EDT
4.05
+0.07 (1.76%)
After-hours: May 12, 2026, 6:09 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.98
+0.02 (0.51%)
At close: May 12, 2026, 4:00 PM EDT
4.05
+0.07 (1.76%)
After-hours: May 12, 2026, 6:09 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.86 | 6.05 | 10 | |
| Quick ratio | 2.86 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 10 | |
| Debt to Assets | 0.01 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 42M | 21M | N/A | N/A | 3M |
| Gross Profit | 34M | 15M | -95K | -95K | -95K |
| Operating Income | -88M | -121M | -28M | -27M | -25M |
| Net Income | -85M | -119M | -29M | -18M | -14M |
| EBITDA | -86M | -121M | -28M | -27M | -25M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | 30.43 | 5.5 |
| Next quarter | N/A | -2.42 | 1.0 |
| Current year | N/A | 29.18 | 5.5 |
| Next year | N/A | -0.32 | 1.0 |
| Weighted average score | 3.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -31.62 | -32.19 | -33.53 | 3.3 |
| Y/Y | 999 | 42.75 | 53.57 | -17.62 | 7.8 |
| 3y average | 283.03 | 24.87 | -17.57 | 10.79 | 7.0 |
| 5y average | 169.59 | -214.72 | -222.14 | -185.77 | 3.3 |
| Weighted average score | 5.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $20.7M significantly exceed its total debt $201.0K, ensuring strong financial flexibility
Total current assets $31.5M exceed Total current liabilities $11.0M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$5.7M limits the company's ability to reinvest or pay down debt